双胎妊娠孕早期唐氏筛查效果评估
该研究基于丹麦全国双胎妊娠队列,评估孕早期唐氏筛查在双胎中的表现。仅用年龄和NT筛查时检出率69.6%、假阳性率6.3%;联合生化指标后检出率89.5%、假阳性率7.2%。结论认为优化筛查技术下双胎检出率与单胎相当,但假阳性率近两倍。
要点
- 双胎妊娠联合年龄、NT和生化指标筛查唐氏检出率达89.5%。
- 双胎筛查假阳性率7.2%,近乎单胎的两倍。
- 仅用年龄和NT筛查时双胎检出率降至69.6%。
核心结论
- 采用优化筛查技术时,双胎妊娠唐氏检出率似乎与单胎相当,但假阳性率近两倍。
研究设计与样本
- 回顾性全国队列研究,数据来自丹麦胎儿医学数据库和丹麦中央细胞遗传学登记处。
- 纳入2009至2017年间参与全国孕早期唐氏筛查的双胎妊娠8812例,其中唐氏妊娠42例。
- 风险基于母亲年龄、NT厚度及可获得的生化标志物(β-hCG和PAPP-A)评估。
主要发现
- 仅基于年龄和NT评估(生化数据缺失,n=4693)时,检出率69.6%(95%CI: 50.8%-88.4%),假阳性率6.3%(95%CI: 5.6%-7.0%)。
- 基于年龄、NT和生化三项参数评估(n=4119)时,检出率89.5%(95%CI: 76.7%-100.0%),假阳性率7.2%(95%CI: 6.4%-8.0%)。
临床怎么用
- 双胎妊娠孕早期筛查应尽量联合生化标志物以提高唐氏检出率。
- 咨询时需告知双胎筛查假阳性率较高,可能增加侵入性产前诊断需求。
局限性
- 回顾性研究设计可能存在数据缺失偏倚(如4693例缺乏生化指标)。
- 检出率置信区间较宽,尤其联合筛查组上限达100.0%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the performance of the Danish first trimester screening program in twin pregnancies. METHOD: Retrospective, nation-wide, cohort study with data collected from the Danish Fetal Medicine Database (DFMD) and The Danish Central Cytogenetic Registry (DCCR). The cohort included all women with twin pregnancies participating in the national first trimester screening program for Trisomy 21. Risk assessment was based on maternal age, nuchal translucency (NT) thickness and, if available, biochemical markers (β-hCG and PAPP-A). RESULTS: 8812 twin pregnancies including 42 pregnancies with Trisomy 21 had a risk assessment between 2009 and 2017. The detection rate (DR) for pregnancies with a risk assessment based on maternal age and NT only (missing data on biochemical markers, n = 4693) was 69.6% (95% CI: 50.8%-88.4%) for a 6.3% false positive rate (FPR) (95% CI: 5.6%-7.0%), whereas for pregnancies with a risk assessment based on all three parameters (n = 4119) the DR was 89.5% (95% CI: 76.7%-100.0%) for a 7.2% FPR (95% CI: 6.4%-8.0%). CONCLUSION: The DR of Trisomy 21 in twin pregnancies, seems as high as for singleton pregnancies, when using optimal screening techniques, but the FPR is nearly twice as high.
引用
- Bergstrand E, Borregaard Miltoft C, Tabor A, et al. Performance of first trimester screening for Trisomy 21 in twin pregnancies. Prenat Diagn. 2020. PMID: 33128403. doi:10.1002/pd.5857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。